paclitaxel has been researched along with Eccrine Porocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boulinguez, S; Chira, C; Godillot, C; Meyer, N; Paul, C; Riffaud, L; Sibaud, V; Tournier, E | 1 |
1 other study(ies) available for paclitaxel and Eccrine Porocarcinoma
| Article | Year |
|---|---|
Complete response of a metastatic porocarcinoma treated with paclitaxel, cetuximab and radiotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cetuximab; Chemoradiotherapy, Adjuvant; Eccrine Porocarcinoma; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Sweat Gland Neoplasms | 2018 |